<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35809130</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1590-3478</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>10</Issue><PubDate><Year>2022</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology</Title><ISOAbbreviation>Neurol Sci</ISOAbbreviation></Journal><ArticleTitle>Human tissue lead (Pb) levels and amyotrophic lateral sclerosis: a systematic review and meta-analysis of case-control studies.</ArticleTitle><Pagination><StartPage>5851</StartPage><EndPage>5859</EndPage><MedlinePgn>5851-5859</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10072-022-06237-y</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To combine the current scientific literature evidence and elucidate the differences of lead (Pb) bioaccumulation in human tissues by comparing amyotrophic lateral sclerosis (ALS) patients and healthy controls.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We systematically searched for case-control studies on the association of Pb levels with ALS, in human cells, tissues, and body fluids (nervous tissue, muscle, blood, cerebrospinal fluid, urine, skin appendages). Then, we performed a meta-analysis for all the tissues in which at least five case-control studies were available: whole blood (9 studies), serum/plasma (5 studies), and cerebrospinal fluid (CSF) (6 studies). Differences between cases and controls were evaluated using standardized mean difference, and combined estimates were derived using random effect maximum likelihood (REML) meta-analyses.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 1734 records, we identified 46 full-text studies, of which 14 case-control studies met the meta-analysis inclusion criteria. We found higher Pb levels in ALS cases than controls in blood (standardized mean difference (SMD)&#x2009;=&#x2009;0.61; 95% confidence interval (CI) 0.20, 1.01; p&#x2009;=&#x2009;0.003), plasma/serum (SMD&#x2009;=&#x2009;0.27; 95% CI&#x2009;-&#x2009;0.16, 0.70; p&#x2009;=&#x2009;0.26), and CSF (SMD&#x2009;=&#x2009;0.53; 95% CI&#x2009;-&#x2009;0.09, 1.15; p&#x2009;=&#x2009;0.09).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This work provides further evidence of the association between Pb bioaccumulation and ALS in body fluids. The lack of association studies in solid tissues did not allow a robust meta-analysis. Future prospective studies are needed to clarify the causality in the association of Pb bioaccumulation with ALS.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Farace</LastName><ForeName>Cristiano</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences-Histology, University of Sassari, Viale S. Pietro 43b, 07100, Sassari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Biostructure and Biosystem, Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Fiorito</LastName><ForeName>Giovanni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Science-Hygiene, University of Sassari, Sassari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health, Imperial College, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pisano</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6050-2756</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Sciences-Histology, University of Sassari, Viale S. Pietro 43b, 07100, Sassari, Italy. pisanoandrea87@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Etzi</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences-Histology, University of Sassari, Viale S. Pietro 43b, 07100, Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sabalic</LastName><ForeName>Angela</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences-Histology, University of Sassari, Viale S. Pietro 43b, 07100, Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fenu</LastName><ForeName>Grazia</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences-Histology, University of Sassari, Viale S. Pietro 43b, 07100, Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Asara</LastName><ForeName>Yolande</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences-Histology, University of Sassari, Viale S. Pietro 43b, 07100, Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Solinas</LastName><ForeName>Giuliana</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Science-Hygiene, University of Sassari, Sassari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Madeddu</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences-Histology, University of Sassari, Viale S. Pietro 43b, 07100, Sassari, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute of Biostructure and Biosystem, Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>FAR-2020</GrantID><Agency>Universit&#xe0; degli Studi di Sassari</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D000078182">Systematic Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Italy</Country><MedlineTA>Neurol Sci</MedlineTA><NlmUniqueID>100959175</NlmUniqueID><ISSNLinking>1590-1874</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>2P299V784P</RegistryNumber><NameOfSubstance UI="D007854">Lead</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007854" MajorTopicYN="N">Lead</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis (ALS)</Keyword><Keyword MajorTopicYN="N">Blood</Keyword><Keyword MajorTopicYN="N">Cerebrospinal fluid (CSF)</Keyword><Keyword MajorTopicYN="N">Lead (Pb)</Keyword><Keyword MajorTopicYN="N">Meta-analysis</Keyword><Keyword MajorTopicYN="N">Plasma</Keyword></KeywordList><CoiStatement>We declare that none of the authors have conflict of interest with this publication.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>5</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>6</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>7</Month><Day>9</Day><Hour>11</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35809130</ArticleId><ArticleId IdType="pmc">PMC9474539</ArticleId><ArticleId IdType="doi">10.1007/s10072-022-06237-y</ArticleId><ArticleId IdType="pii">10.1007/s10072-022-06237-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A, et al. Amyotrophic lateral sclerosis. Nat Rev Dis Primers. 2017;3:1&#x2013;18. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">29052611</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G, Piccininni M. Amyotrophic lateral sclerosis descriptive epidemiology: the origin of geographic difference. Neuroepidemiology. 2019;52(1&#x2013;2):3&#x2013;103. doi: 10.1159/000493386.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000493386</ArticleId><ArticleId IdType="pubmed">30602169</ArticleId></ArticleIdList></Reference><Reference><Citation>Westeneng HJ, Debray TPA, Visser AE, et al. Prognosis for patients with amyotrophic lateral sclerosis: development and validation of a personalised prediction model. Lancet Neurol. 2018;17:423&#x2013;433. doi: 10.1016/S1474-4422(18)30089-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30089-9</ArticleId><ArticleId IdType="pubmed">29598923</ArticleId></ArticleIdList></Reference><Reference><Citation>Volk AE, Weishaupt JH, Andersen PM, et al. Current knowledge and recent insights into the genetic basis of amyotrophic lateral sclerosis. Medizinische Genetik. 2018;30:252&#x2013;258. doi: 10.1007/s11825-018-0185-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11825-018-0185-3</ArticleId><ArticleId IdType="pmc">PMC6132774</ArticleId><ArticleId IdType="pubmed">30220791</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta PR, Jones AR, Opie-Martin S, et al. Younger age of onset in familial amyotrophic lateral sclerosis is a result of pathogenic gene variants, rather than ascertainment bias. J Neurol Neurosurg Psychiatry. 2019;90:268&#x2013;271. doi: 10.1136/jnnp-2018-319089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319089</ArticleId><ArticleId IdType="pmc">PMC6518463</ArticleId><ArticleId IdType="pubmed">30270202</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C, Roos PM, Piehl F, et al. Risk factors for amyotrophic lateral sclerosis. Clin Epidemiol. 2015;7:181&#x2013;193. doi: 10.2147/CLEP.S37505.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S37505</ArticleId><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W. Neurotoxicology of the brain barrier system: new implications. J Toxicol-Clin Toxicol. 2001;39:711&#x2013;719. doi: 10.1081/CLT-100108512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1081/CLT-100108512</ArticleId><ArticleId IdType="pmc">PMC4111935</ArticleId><ArticleId IdType="pubmed">11778669</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders T, Liu Y, Buchner V, Tchounwou PB. Neurotoxic effects and biomarkers of lead exposure: a review. Rev Environ Health. 2009;24:15&#x2013;45. doi: 10.1515/REVEH.2009.24.1.15.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/REVEH.2009.24.1.15</ArticleId><ArticleId IdType="pmc">PMC2858639</ArticleId><ArticleId IdType="pubmed">19476290</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W (2001) Toxicology of choroid plexus: special reference to metal-induced neurotoxicities. Microsc Res Tech 52:89&#x2013;103.&#xa0;10.1002/1097-0029(20010101)52:1&lt;89::AID-JEMT11&gt;3.0.CO;2-2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4126155</ArticleId><ArticleId IdType="pubmed">11135452</ArticleId></ArticleIdList></Reference><Reference><Citation>Farace C, Fenu G, Lintas S et al (2020) Amyotrophic lateral sclerosis and lead: a systematic update.&#xa0;NeuroToxicology&#xa0;81:80&#x2013;88. 10.1016/j.neuro.2020.09.003</Citation><ArticleIdList><ArticleId IdType="pubmed">32941938</ArticleId></ArticleIdList></Reference><Reference><Citation>Moher D, Liberati A, Tetzlaff J et al (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097. 10.1371/journal.pmed.1000097</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2707599</ArticleId><ArticleId IdType="pubmed">19621072</ArticleId></ArticleIdList></Reference><Reference><Citation>Borenstein M, Hedges LV, Higgins JPT, Rothstein HR. A basic introduction to fixed-effect and random-effects models for meta-analysis. Res Synth Methods. 2010;1:97&#x2013;111. doi: 10.1002/jrsm.12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jrsm.12</ArticleId><ArticleId IdType="pubmed">26061376</ArticleId></ArticleIdList></Reference><Reference><Citation>Weir CJ, Butcher I, Assi V, et al. Dealing with missing standard deviation and mean values in meta-analysis of continuous outcomes: a systematic review. BMC Med Res Methodol. 2018;18:1&#x2013;14. doi: 10.1186/s12874-018-0483-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12874-018-0483-0</ArticleId><ArticleId IdType="pmc">PMC5842611</ArticleId><ArticleId IdType="pubmed">29514597</ArticleId></ArticleIdList></Reference><Reference><Citation>Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. J Stat Softw 36:1&#x2013;48. 10.18637/jss.v036.i03</Citation></Reference><Reference><Citation>De Benedetti S, Lucchini G, Del B&#xf2; C, et al. Blood trace metals in a sporadic amyotrophic lateral sclerosis geographical cluster. BioMetals. 2017;30:355&#x2013;365. doi: 10.1007/s10534-017-0011-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10534-017-0011-4</ArticleId><ArticleId IdType="pubmed">28337565</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F, Kwee LC, Allen KD, et al. Association between blood lead and the risk of amyotrophic lateral sclerosis. Am J Epidemiol. 2010;171:1126&#x2013;1133. doi: 10.1093/aje/kwq063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwq063</ArticleId><ArticleId IdType="pmc">PMC2877471</ArticleId><ArticleId IdType="pubmed">20406759</ArticleId></ArticleIdList></Reference><Reference><Citation>Sienko DG, Davis JP, Taylor JA, Brooks BR. Amyotrophic lateral sclerosis: a case-control study following detection of a cluster in a small wisconsin community. Arch Neurol. 1990;47:38&#x2013;41. doi: 10.1001/archneur.1990.00530010046017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.1990.00530010046017</ArticleId><ArticleId IdType="pubmed">2294892</ArticleId></ArticleIdList></Reference><Reference><Citation>Stober T, Stelte W, Kunze K. Lead concentrations in blood, plasma, erythrocytes, and cerebrospinal fluid in amyotrophic lateral sclerosis. J Neurol Sci. 1983;61:21&#x2013;26. doi: 10.1016/0022-510X(83)90051-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(83)90051-5</ArticleId><ArticleId IdType="pubmed">6631450</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M, Guidetti D, Bergomi M, et al. Lead, cadmium, and selenium in the blood of patients with sporadic amyotrophic lateral sclerosis. Ital J Neurol Sci. 1997;18:87&#x2013;92. doi: 10.1007/BF01999568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01999568</ArticleId><ArticleId IdType="pubmed">9239528</ArticleId></ArticleIdList></Reference><Reference><Citation>Garzillo EM, Lamberti M, Genovese G, et al. Blood lead, manganese, and aluminum levels in a regional Italian cohort of ALS patients does aluminum have an influence? J Occup Environ Med. 2014;56:1062&#x2013;1066. doi: 10.1097/JOM.0000000000000266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JOM.0000000000000266</ArticleId><ArticleId IdType="pubmed">25285828</ArticleId></ArticleIdList></Reference><Reference><Citation>Oggiano R, Solinas G, Forte G, et al. Trace elements in ALS patients and their relationships with clinical severity. Chemosphere. 2018;197:457&#x2013;466. doi: 10.1016/j.chemosphere.2018.01.076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chemosphere.2018.01.076</ArticleId><ArticleId IdType="pubmed">29366958</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin X, Wu P, Wen T, et al. Comparative assessment of blood metal/metalloid levels, clinical heterogeneity, and disease severity in amyotrophic lateral sclerosis patients. Neurotoxicology. 2022;89:12&#x2013;19. doi: 10.1016/j.neuro.2022.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2022.01.003</ArticleId><ArticleId IdType="pubmed">35007622</ArticleId></ArticleIdList></Reference><Reference><Citation>Eum KD, Seals RM, Taylor KM et al (2015) Modification of the association between lead exposure and amyotrophic lateral sclerosis by iron and oxidative stress related gene polymorphisms.&#xa0;Amyotroph Lateral Scler Frontotemporal Degener&#xa0;16:72&#x2013;79. 10.3109/21678421.2014.964259</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4467726</ArticleId><ArticleId IdType="pubmed">25293352</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos PM, Vesterberg O, Syversen T, et al. Metal concentrations in cerebrospinal fluid and blood plasma from patients with amyotrophic lateral sclerosis. Biol Trace Elem Res. 2013;151:159&#x2013;170. doi: 10.1007/s12011-012-9547-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12011-012-9547-x</ArticleId><ArticleId IdType="pubmed">23225075</ArticleId></ArticleIdList></Reference><Reference><Citation>Conradi S, Ronnevi LO, Vesterberg O. Increased plasma levels of lead in patients with amyotrophic lateral sclerosis compared with control subjects as determined by flameless atomic absorption spectrophotometry. J Neurol Neurosurg Psychiatry. 1978;41:389&#x2013;393. doi: 10.1136/jnnp.41.5.389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.41.5.389</ArticleId><ArticleId IdType="pmc">PMC493043</ArticleId><ArticleId IdType="pubmed">77896</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapaki E, Segditsa J, Zournas C, et al. Determination of cerebrospinal fluid and serum lead levels in patients with amyotrophic lateral sclerosis and other neurological diseases. Experientia. 1989;45:1108&#x2013;1110. doi: 10.1007/BF01950171.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01950171</ArticleId><ArticleId IdType="pubmed">2599056</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M, Filippini T, Mandrioli J, et al. Lead, cadmium and mercury in cerebrospinal fluid and risk of amyotrophic lateral sclerosis: a case-control study. J Trace Elem Med Biol. 2017;43:121&#x2013;125. doi: 10.1016/j.jtemb.2016.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtemb.2016.12.012</ArticleId><ArticleId IdType="pmc">PMC5495626</ArticleId><ArticleId IdType="pubmed">28089071</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalleri A, Minoia C, Ceroni M, Poloni M. Lead in cerebrospinal fluid and its relationship to plasma lead in humans. J Appl Toxicol. 1984;4:63&#x2013;65. doi: 10.1002/jat.2550040202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jat.2550040202</ArticleId><ArticleId IdType="pubmed">6736552</ArticleId></ArticleIdList></Reference><Reference><Citation>Conradi S, Ronnevi LO, Nise G, Vesterberg O. Abnormal distribution of lead in amyotrophic lateral sclerosis. Reestimation of lead in the cerebrospinal fluid. J Neurol Sci. 1980;48:413&#x2013;418. doi: 10.1016/0022-510X(80)90112-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(80)90112-4</ArticleId><ArticleId IdType="pubmed">7441289</ArticleId></ArticleIdList></Reference><Reference><Citation>Radunovic A, Annane D, Rafiq MK et al (2017) Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev 2017:CD004427.&#xa0;10.1002/14651858.CD004427.pub4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6485636</ArticleId><ArticleId IdType="pubmed">28982219</ArticleId></ArticleIdList></Reference><Reference><Citation>Goel AD, Chowgule RV. Outbreak investigation of lead neurotoxicity in children from artificial jewelry cottage industry. Environ Health Prev Med. 2019;24:1&#x2013;5. doi: 10.1186/s12199-019-0777-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12199-019-0777-9</ArticleId><ArticleId IdType="pmc">PMC6511187</ArticleId><ArticleId IdType="pubmed">31077132</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocha A, Trujillo KA. Neurotoxicity of low-level lead exposure: history, mechanisms of action, and behavioral effects in humans and preclinical models. NeuroToxicology. 2019;73:58&#x2013;80. doi: 10.1016/j.neuro.2019.02.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2019.02.021</ArticleId><ArticleId IdType="pmc">PMC7462347</ArticleId><ArticleId IdType="pubmed">30836127</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazliah J, Barron S, Bental E, et al. The effects of long-term lead intoxication on the nervous system of the chicken. Neurosci Lett. 1989;101:253&#x2013;257. doi: 10.1016/0304-3940(89)90541-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(89)90541-7</ArticleId><ArticleId IdType="pubmed">2771171</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu KS, Hao JH, Zeng Y, et al. Neurotoxicity and biomarkers of lead exposure: a review. Chin Med Sci J. 2013;28:178&#x2013;188. doi: 10.1016/S1001-9294(13)60045-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1001-9294(13)60045-0</ArticleId><ArticleId IdType="pubmed">24074621</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xfc;tz A, Bergdahl IA, Ekholm A, Skerfving S. Measurement by ICP-MS of lead in plasma and whole blood of lead workers and controls. Occup Environ Med. 1996;53:736&#x2013;740. doi: 10.1136/oem.53.11.736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/oem.53.11.736</ArticleId><ArticleId IdType="pmc">PMC1128590</ArticleId><ArticleId IdType="pubmed">9038796</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergdahl IA, Grubb A, Sch&#xfc;tz A, et al. Lead binding to &#x3b4;-aminolevulinic acid dehydratase (ALAD) in human erythrocytes. Pharmacol Toxicol. 1997;81:153&#x2013;158. doi: 10.1111/j.1600-0773.1997.tb02061.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0773.1997.tb02061.x</ArticleId><ArticleId IdType="pubmed">9353844</ArticleId></ArticleIdList></Reference><Reference><Citation>de Souza ID, de Andrade AS, Dalmolin RJS. Lead-interacting proteins and their implication in lead poisoning. Crit Rev Toxicol. 2018;48:375&#x2013;386. doi: 10.1080/10408444.2018.1429387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408444.2018.1429387</ArticleId><ArticleId IdType="pubmed">29431551</ArticleId></ArticleIdList></Reference><Reference><Citation>Paglia DE, Valentine WN, Dahlgren JG. Effects of low level lead exposure on pyrimidine 5&#x2019; nucleotidase and other erythrocyte enzymes. Possible role of pyrimidine 5&#x2019; nucleotidase in the pathogenesis of lead induced anemia. J Clin Investig. 1975;56:1164&#x2013;1169. doi: 10.1172/JCI108192.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI108192</ArticleId><ArticleId IdType="pmc">PMC301979</ArticleId><ArticleId IdType="pubmed">1184742</ArticleId></ArticleIdList></Reference><Reference><Citation>Barry PSI. Concentrations of lead in the tissues of children. Br J Ind Med. 1981;38:61&#x2013;71. doi: 10.1136/oem.38.1.61.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/oem.38.1.61</ArticleId><ArticleId IdType="pmc">PMC1008800</ArticleId><ArticleId IdType="pubmed">7193476</ArticleId></ArticleIdList></Reference><Reference><Citation>Barry PSI. A comparison of concentrations of lead in human tissues. Br J Ind Med. 1975;32:119&#x2013;139. doi: 10.1136/oem.32.2.119.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/oem.32.2.119</ArticleId><ArticleId IdType="pmc">PMC1008038</ArticleId><ArticleId IdType="pubmed">1131339</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyake M, Ishigaki K, Suzuki T. Structure refinements of Pb2+ ion-exchanged apatites by X-ray powder pattern-fitting. J Solid State Chem. 1986;61:230&#x2013;235. doi: 10.1016/0022-4596(86)90026-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-4596(86)90026-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Apostolski S, Nikoli&#x107; J, Bugarski-Prokopljevi&#x107; C, et al. Serum and CSF immunological findings in ALS. Acta Neurol Scand. 1991;83:96&#x2013;98. doi: 10.1111/j.1600-0404.1991.tb04656.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1991.tb04656.x</ArticleId><ArticleId IdType="pubmed">2017904</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarasiuk J, Ku&#x142;akowska A, Drozdowski W, et al. CSF markers in amyotrophic lateral sclerosis. J Neural Transm. 2012;119:747&#x2013;757. doi: 10.1007/s00702-012-0806-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-012-0806-y</ArticleId><ArticleId IdType="pubmed">22555610</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinceti M, Bottecchi I, Fan A, et al. Are environmental exposures to selenium, heavy metals, and pesticides risk factors for amyotrophic lateral sclerosis. Rev Environ Health. 2012;27:19&#x2013;41. doi: 10.1515/reveh-2012-0002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/reveh-2012-0002</ArticleId><ArticleId IdType="pubmed">22755265</ArticleId></ArticleIdList></Reference><Reference><Citation>Dudev T, Grauffel C, Lim C (2018) How Pb2+ binds and modulates properties of Ca2+-signaling proteins. Inorg Chem 57:14798&#x2013;14809. 10.1021/acs.inorgchem.8b02548</Citation><ArticleIdList><ArticleId IdType="pubmed">30411871</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization International Agency for Research on Cancer Inorganic and organic lead compounds. IARC monographs on the evaluation of carcinogenic risks to humans. 2006;87:1&#x2013;471.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4781642</ArticleId><ArticleId IdType="pubmed">17191367</ArticleId></ArticleIdList></Reference><Reference><Citation>Ash PEA, Dhawan U, Boudeau S, et al. Heavy metal neurotoxicants induce ALS-linked TDP-43 pathology. Toxicol Sci. 2019;167:105&#x2013;115. doi: 10.1093/toxsci/kfy267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfy267</ArticleId><ArticleId IdType="pmc">PMC6317426</ArticleId><ArticleId IdType="pubmed">30371865</ArticleId></ArticleIdList></Reference><Reference><Citation>Julian TH, Boddy S, Islam M, et al. A review of Mendelian randomization in amyotrophic lateral sclerosis. Brain. 2022;145:832&#x2013;842. doi: 10.1093/brain/awab420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab420</ArticleId><ArticleId IdType="pmc">PMC9050546</ArticleId><ArticleId IdType="pubmed">34791088</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>